| THALIA THERAPEUTICS |
| Großbritannien |
| Gesundheit |
| GB00BYW8QM32 / A2DQES |
| 0GO (Frankfurt) |
| FRA:0GO, ETR:0GO, 0GO:GR |
| - |
| https://www.thaliatx.com/ |
|
Thalia Therapeutics Plc is a biotechnology company developing RNA-based therapeutics and delivery technologies for oncology and cardiovascular disease. The company's proprietary Nuvec delivery system uses amorphous silica nanoparticles with an irregu..
>Volltext.. |
| 5.52 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| THALIA THERAPEUTICS, THALIA THERAPEUTIC, N4 PHARMA |
| 23.04.26 |
|
||||
|